Hatcher J F, Rao K P, Swaminathan S
Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, Madison 53792.
Mutagenesis. 1993 Mar;8(2):113-20. doi: 10.1093/mutage/8.2.113.
Activation of the human bladder carcinogen 4-aminobiphenyl (ABP) and its N-hydroxy derivatives was investigated using lysates and subcellular enzyme preparations from cultured human uroepithelial cells (HUC). Mutagenic activation was determined using Salmonella typhimurium strains TA98; TA98/1,8-DNP6, a derivative deficient in acetyl coenzyme A:N-hydroxyarylamine O-acetyltransferase (OAT); and YG1024, a derivative of TA98 with elevated OAT activity and enhanced sensitivity to mutation by N-hydroxyarylamines. Mutagenicity of ABP catalyzed by HUC microsomes was detected in YG1024 but not in the parent strain TA98. HUC microsomes also catalyzed the mutagenic activation of N-hydroxy-4-acetylaminobiphenyl (N-OH-AABP) and the relative sensitivity of the tester strains was YG1024 > TA98 > TA98/1,8-DNP6, indicating N-hydroxy-4-aminobiphenyl (N-OH-ABP) as the mutagenic intermediate. In contrast, the mutagenic activity of N-acetoxy-4-acetylaminobiphenyl incubated with HUC microsomes was approximately equal in TA98 and YG1024, and may involve N-acetoxy-4-aminobiphenyl (N-OAc-ABP) as the intermediate. High pressure liquid chromatography (HPLC) of the DNA hydrolysate obtained after incubation of [3H]N-OH-ABP with YG1024, showed N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG-ABP) as the primary adduct, based on mobility of the radioactivity in comparison with the synthetic standard. Additionally, HUC microsomes catalyzed the binding of [3H]N-OH-ABP to RNA in the presence of 4-acetylaminobiphenyl (AABP), N-OH-AABP and acetyl coenzyme A as acetyl donors, and this binding was blocked by paraoxon. The hydrolysate obtained from incubation of DNA with [3H]N-OH-ABP and HUC microsomes, with AABP as acetyl donor, revealed the formation of dG-ABP adduct.(ABSTRACT TRUNCATED AT 250 WORDS)
利用培养的人尿道上皮细胞(HUC)的裂解物和亚细胞酶制剂,研究了人类膀胱致癌物4-氨基联苯(ABP)及其N-羟基衍生物的活化情况。使用鼠伤寒沙门氏菌菌株TA98、TA98/1,8-DNP6(一种缺乏乙酰辅酶A:N-羟基芳胺O-乙酰基转移酶(OAT)的衍生物)和YG1024(TA98的一种衍生物,具有升高的OAT活性且对N-羟基芳胺诱导的突变敏感性增强)来测定诱变活化。HUC微粒体催化的ABP诱变性在YG1024中被检测到,但在亲本菌株TA98中未被检测到。HUC微粒体还催化了N-羟基-4-乙酰氨基联苯(N-OH-AABP)的诱变活化,测试菌株的相对敏感性为YG1024 > TA98 > TA98/1,8-DNP6,表明N-羟基-4-氨基联苯(N-OH-ABP)是诱变中间体。相比之下,与HUC微粒体一起孵育的N-乙酰氧基-4-乙酰氨基联苯的诱变活性在TA98和YG1024中大致相等,并且可能涉及N-乙酰氧基-4-氨基联苯(N-OAc-ABP)作为中间体。在将[3H]N-OH-ABP与YG1024孵育后获得的DNA水解产物的高压液相色谱(HPLC)显示,基于放射性与合成标准品相比的迁移率,N-(脱氧鸟苷-8-基)-4-氨基联苯(dG-ABP)是主要加合物。此外,在4-乙酰氨基联苯(AABP)、N-OH-AABP和乙酰辅酶A作为乙酰供体存在的情况下,HUC微粒体催化[3H]N-OH-ABP与RNA的结合,并且这种结合被对氧磷阻断。以AABP作为乙酰供体,将DNA与[3H]N-OH-ABP和HUC微粒体一起孵育后获得的水解产物显示形成了dG-ABP加合物。(摘要截短于250字)